Xtx Topco LTD Concert Pharmaceuticals, Inc. Transaction History

Xtx Topco LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$2.8 - $6.36 $83,344 - $189,311	29,766 New	29,766 $125,000
Q1 2022 May 13, 2022	SELL	$2.73 - $3.94 $39,052 - $56,361	-14,305 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$2.69 - $4.22 $38,480 - $60,367	14,305 New	14,305 $45,000
Q2 2021 Aug 12, 2021	SELL	$3.77 - $5.24 $113,514 - $157,776	-30,110 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$4.86 - $13.07 $146,334 - $393,537	30,110 New	30,110 $150,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.